Andersen-Tawil syndrome
Channelopathy · Cardiac
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Rare channelopathy with the triad of periodic paralysis, ventricular arrhythmias (prominent U waves, ventricular ectopy) and dysmorphic features.
Red flags
- Sustained ventricular tachycardia
- Syncope
- Severe potassium swings
- Respiratory involvement during paralysis
Assessment
Differential diagnosis
- Long QT syndrome
- Thyrotoxic periodic paralysis
- Hypokalaemic periodic paralysis
- CPVT
- Hypokalaemia of other cause
Investigations
- 12-lead ECG (prominent U waves, bidirectional/ventricular ectopy)
- Serum potassium during episodes
- Continuous telemetry
- Thyroid function to exclude mimics
- Genetic referral
Management
- Continuous cardiac monitoring
- Cautiously correct potassium disturbance during paralytic episodes
- Treat sustained ventricular arrhythmia per ALS
- Avoid QT-prolonging drugs
- Refer to inherited cardiac conditions service
- Manage recurrent paralysis with specialist input
Drugs & doses
Potassium replacement (guided by level and phase)
Beta-blocker or flecainide for arrhythmia (specialist)
Acetazolamide for paralysis (specialist)
Disposition
Admit for monitoring; specialist referral.
Complications & pitfalls
- Ventricular arrhythmia
- Recurrent paralysis / falls
- Cardiac arrest (uncommon)
Exam pearls
- Ventricular ectopy is frequent but often better tolerated than in other channelopathies.
- Potassium level may be high, low or normal during paralytic attacks.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.